SWA
ENTA icon

Sutton Wealth Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History

Sutton Wealth Advisors’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-509
Closed -$23.7K – 1035
2022
Q4 		$23.7K Buy
509
+1
+0.2% +$46 0.01% 629
2022
Q3 		$26.4K Buy
508
+3
+0.6% +$175 0.01% 569
2022
Q2 		$23.9K Sell
505
-6
-1% -$326 0.01% 611
2022
Q1 		$36.4K Buy
511
+1
+0.2% +$65 0.01% 507
2021
Q4 		$38.1K Buy
510
+5
+1% +$392 0.01% 500
2021
Q3 		$28.7K Buy
505
+13
+3% +$643 0.01% 578
2021
Q2 		$21.7K Hold
492
– – 0.01% 678
2021
Q1 		$24.3K Hold
492
– – 0.01% 615
2020
Q4 		$20.7K Hold
492
– – 0.01% 602
2020
Q3 		$22.5K Hold
492
– – 0.01% 507
2020
Q2 		$24.7K Hold
492
– – 0.01% 474
2020
Q1 		$25.3K Hold
492
– – 0.02% 415
2019
Q4 		$30.4K Hold
492
– – 0.02% 448
2019
Q3 		$29.6K Hold
492
– – 0.02% 455
2019
Q2 		$41.5K Hold
492
– – 0.02% 347
2019
Q1 		$47K Hold
492
– – 0.03% 313
2018
Q4 		$34.8K Hold
492
– – 0.02% 353
2018
Q3 		$42K Hold
492
– – 0.03% 327
2018
Q2 		$57K Hold
492
– – 0.04% 257
2018
Q1 		$39.8K Hold
492
– – 0.03% 334
2017
Q4 		$28.9K Hold
492
– – 0.02% 424
2017
Q3 		$23K Hold
492
– – 0.02% 498
2017
Q2 		$17.7K Hold
492
– – 0.01% 581
2017
Q1 		$15.2K Hold
492
– – 0.01% 600
2016
Q4 		$16.5K Hold
492
– – 0.01% 554
2016
Q3 		$13.1K Hold
492
– – 0.01% 587
2016
Q2 		$10.8K Buy
+492
New +$12.9K 0.01% 610

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sutton Wealth Advisors's ENTA Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Enanta Pharmaceuticals (ENTA) in Q1 2023, closing a stake of 509 shares — an estimated $23.7K sold.

Sutton Wealth Advisors first reported a position in ENTA in Q2 2016 and held it in 27 quarters. The position peaked at $57K in Q2 2018. 144 funds tracked by Wall St. Rank hold ENTA as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Enanta Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 509 Enanta Pharmaceuticals shares in Q1 2023, an estimated $23.7K.
  • Sutton Wealth Advisors first reported a position in Enanta Pharmaceuticals in Q2 2016 and held it in 27 quarters.
  • Sutton Wealth Advisors's Enanta Pharmaceuticals position peaked at $57K in Q2 2018.
  • 144 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.